InvestorsHub Logo
Followers 4
Posts 585
Boards Moderated 0
Alias Born 03/12/2010

Re: SquirrelCage post# 29157

Tuesday, 03/19/2019 1:12:38 PM

Tuesday, March 19, 2019 1:12:38 PM

Post# of 36194
Yep lifeline biotechnologies investor update previously released...clinical release, ENHANCSD INVESTOR VALUE, etc.
https://www.apnews.com/b2a410b2d7def8abcc68c79a07f96332

(Previous article discusses patent, strategy, etc)
"The License and Collaboration Agreement between CI and CA brings advantages for both parties," said Royea. "The opportunity for early market entry and funding from the Asian operations brings additional funding into CI to exercise its option, under an Intellectual Property Asset Option Agreement with the technology's developer to acquire directly certain patents which previously had been licensed to CI. Those patents are in the process of transferring to CI to be fully owned by CI, and they are licensed to CA under the License and Collaboration Agreement. Furthermore, the License and Collaboration Agreement allows for CI and CA to cooperate on global expansion of the intellectual property portfolio."

Under the License and Collaboration Agreement, CI and CA have also established a joint venture, Cyrcadia Data Services, Ltd. to fund and develop the Cyrcadia health predictive analytics core lab. This entity will ensure improved accuracy in the technology as the companies feed in large volumes of data from their respective regions.

CI's CEO Matt Benardis, sees the new structure as a win-win for all parties. "The new partnership with Cyrcadia Asia, Ltd. provides an accelerated speed to market globally," said Benardis. "The Cyrcadia Health brand recognition that we can achieve together in large populations, along with the significant expansion of powerful intellectual property, is intended to maximize CI shareholder value as we move to our planned market launch here in North America. The joint venture of our unified predictive analytic core lab is intended to provide the highest possible accuracy for patients and providers of our technology throughout the world."
https://www.benzinga.com/pressreleases/17/04/p9339511/cyrcadia-inc-prepares-for-itbra-product-launch-and-expands-strategic-op

tic toc tic toc...


New, but old diff source...article:
https://www.google.com/amp/en.businesstimes.cn/amp/articles/106351/20190107/dense-breasted-women-at-risk-of-breast-cancer-high-tech-bra-aids-early-detection.htm